Chronic myelogenous leukemia following radiotherapy and chemotherapy for non-Hodgkin lymphoma.
We report here a women who developed chronic myelogenous leukemia (CML) after successful radiotherapy and chemotherapy for non-Hodgkin lymphoma. Review of the literature indicates that exposure to ionizing radiation is associated with an increased risk of CML.
Cazzola
M
M
Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, Italy.
Bergamaschi
G
G
Melazzini
M
M
Ponchio
L
L
Rosti
V
V
Molinari
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D016313:Genes, abl / Q000528:radiation effects; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D009959:Oropharyngeal Neoplasms / Q000532:radiotherapy*; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone